Yongping Song

2.3k total citations · 1 hit paper
28 papers, 1.7k citations indexed

About

Yongping Song is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yongping Song has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Yongping Song's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yongping Song is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yongping Song collaborates with scholars based in China, United States and Norway. Yongping Song's co-authors include Delong Liu, Shuhang Wang, Zhibo Han, Shuhang Wang, Qian Chu, Kongming Wu, Anping Li, Shuang Qin, Ming Yi and Shundong Cang and has published in prestigious journals such as Analytical Chemistry, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Yongping Song

26 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

2019 290 citations Yongping Song et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongping Song China	16	866	717	459	440	256	28	1.7k
Joe Stephenson United States	25	894 1.0×	1.1k 1.5×	488 1.1×	429 1.0×	360 1.4×	65	2.0k
Akintunde Akinleye United States	11	660 0.8×	742 1.0×	224 0.5×	343 0.8×	164 0.6×	13	1.5k
Eva M. Garrido‐Martín Spain	19	615 0.7×	545 0.8×	306 0.7×	617 1.4×	164 0.6×	36	1.6k
Luigi Formisano Italy	25	1.1k 1.3×	1.1k 1.5×	772 1.7×	165 0.4×	494 1.9×	73	2.2k
Yanis Boumber United States	22	1.6k 1.8×	699 1.0×	420 0.9×	192 0.4×	471 1.8×	56	2.3k
Ling Cen United States	17	626 0.7×	569 0.8×	151 0.3×	251 0.6×	197 0.8×	44	1.3k
László Kopper Hungary	26	821 0.9×	512 0.7×	293 0.6×	146 0.3×	343 1.3×	81	1.6k
Silvestre Vicent Spain	24	1.1k 1.3×	721 1.0×	477 1.0×	361 0.8×	411 1.6×	40	2.0k
Patrick J. Grohar United States	19	1.1k 1.3×	444 0.6×	623 1.4×	117 0.3×	234 0.9×	45	1.7k
Katherine E. Hutchinson United States	19	972 1.1×	920 1.3×	536 1.2×	145 0.3×	595 2.3×	48	1.8k

Countries citing papers authored by Yongping Song

Since Specialization

Citations

This map shows the geographic impact of Yongping Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Song more than expected).

Fields of papers citing papers by Yongping Song

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Song. The network helps show where Yongping Song may publish in the future.

Co-authorship network of co-authors of Yongping Song

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Song. A scholar is included among the top collaborators of Yongping Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Song. Yongping Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Yongping, Chunpu Zou, Junwei Zhao, et al.. (2025). Ultrasensitive Helicobacter pylori DNA Hybridization Detection Based on a No-Core-Fiber Offset Mach–Zehnder Interferometer Enhanced by a MoS ₂ Nanointerface. Analytical Chemistry. 97(42). 23457–23466.

Shi, Yuankai, Keshu Zhou, Hui Zhou, et al.. (2024). Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial. EClinicalMedicine. 73. 102702–102702. 2 indexed citations

Zhao, Lingdi, Tiepeng Li, Yongping Song, et al.. (2022). High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study. Frontiers in Immunology. 12. 779248–779248. 9 indexed citations

Zhang, Qing, Jingjing Yuan, Yanyan Liu, et al.. (2021). KIAA0101 knockdown inhibits cell proliferation and induces cell cycle arrest and cell apoptosis in chronic lymphocytic leukemia cells. Annals of Translational Medicine. 9(6). 487–487. 4 indexed citations

Liu, Yuqing, et al.. (2020). Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy. Frontiers in Immunology. 11. 563653–563653. 22 indexed citations

Song, Yongping, Yue Qin, Keshu Zhou, et al.. (2020). 895P Phase I study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody MIL62 in Chinese patients with relapsed/refractory CD20-positive B-cell non-Hodgkin’s lymphoma. Annals of Oncology. 31. S652–S652. 1 indexed citations

Han, Lu, Quanli Gao, Xiuman Zhou, et al.. (2020). Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade. Cancer Immunology Immunotherapy. 69(8). 1493–1504. 46 indexed citations

Zhang, Tianshun, Ruihua Bai, Qiushi Wang, et al.. (2019). Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non–Small Cell Lung Carcinogenesis. Cancer Prevention Research. 12(12). 837–848. 24 indexed citations

Li, Ning, et al.. (2019). miR-144-3p Suppresses Osteogenic Differentiation of BMSCs from Patients with Aplastic Anemia through Repression of TET2. Molecular Therapy — Nucleic Acids. 19. 619–626. 33 indexed citations

10.

Cang, Shundong, Xiaodong Lv, Ping Wang, et al.. (2017). DDX51 gene promotes proliferation by activating Wnt/β-catenin signaling in breast cancer.. PubMed. 10(11). 10892–10900. 3 indexed citations

11.

Zhou, Keshu, Xiaoyan Feng, Yanying Wang, et al.. (2017). miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11. Experimental Hematology. 58. 27–34.e1. 25 indexed citations

12.

Liu, Bingshan, Yongping Song, & Delong Liu. (2017). Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy. Journal of Hematology & Oncology. 10(1). 174–174. 89 indexed citations

13.

Wang, Shuhang, Yongping Song, & Delong Liu. (2016). EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance. Cancer Letters. 385. 51–54. 236 indexed citations

14.

Han, Lu, Yiman Shang, Yongping Song, & Quanli Gao. (2016). Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells. Journal of Immunology Research. 2016. 1–11. 15 indexed citations

15.

Wang, Zibing, Yuqing Liu, Yiman Shang, et al.. (2016). Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer. Journal of Hematology & Oncology. 9(1). 6–6. 31 indexed citations

16.

Wang, Shuhang, Yongping Song, Feifei Yan, & Delong Liu. (2016). Mechanisms of resistance to third-generation EGFR tyrosine kinase inhibitors. Frontiers of Medicine. 10(4). 383–388. 78 indexed citations

17.

Cang, Shundong, et al.. (2015). ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. Journal of Hematology & Oncology. 8(1). 129–129. 221 indexed citations

18.

Zhang, Yong, Yongping Song, & Quanli Gao. (2015). Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review. Oncology Letters. 10(2). 883–886. 3 indexed citations

19.

Wang, Youwei, et al.. (2012). Safety of Mesenchymal Stem Cells for Clinical Application. Stem Cells International. 2012. 1–4. 174 indexed citations

20.

Song, Yongping. (2010). Evaluation on the safety of structured triglyceride in hematopoietic stem cell transplantation. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact